

A practical guide for providers on helping patients locate Focalin XR during the ongoing shortage. Includes 5 actionable steps and workflow tips.
As a prescriber, you've likely heard the same frustrated refrain from your ADHD patients over the past three years: "My pharmacy doesn't have my Focalin XR." The national stimulant shortage that began in late 2022 continues to disrupt treatment for patients on Dexmethylphenidate ER, and many feel they're navigating it alone.
You can't fix the shortage. But you can significantly reduce the burden it places on your patients. This guide outlines practical, actionable steps you can incorporate into your clinical workflow to help patients maintain access to their ADHD treatment.
As of early 2026, Dexmethylphenidate ER remains on the ASHP drug shortage list. Key points about current availability:
For the latest manufacturer-specific updates, the ASHP Drug Shortage Resource Center is the most reliable source.
Understanding the barriers your patients face can help you intervene more effectively:
Many pharmacies have policies against disclosing inventory for Schedule II medications over the phone, for understandable security reasons. This means patients may need to physically visit multiple pharmacies or rely on their prescriber to call on their behalf.
Large chain pharmacies often have centralized ordering systems with limited flexibility. If the distribution center doesn't have Dexmethylphenidate ER in stock, the pharmacy can't order it — regardless of patient need.
Even when patients find a pharmacy with stock, insurance-related barriers (wrong pharmacy network, prior authorization requirements, quantity limits) can prevent them from filling. Patients dealing with a shortage are often simultaneously dealing with administrative hurdles.
Rural areas and regions with fewer pharmacies are disproportionately affected. A patient in a metropolitan area might have 30 pharmacies to check; a patient in a rural county might have two or three.
Rather than writing a prescription and hoping the patient can fill it, take a proactive approach. Use Medfinder to check which local pharmacies currently have Dexmethylphenidate ER in stock before you send the prescription. This takes 30 seconds and can save your patient hours of frustration.
If Focalin XR isn't available locally, you'll know immediately and can discuss alternatives or direct the prescription to a pharmacy that has stock — even if it's further from the patient's home.
For every patient on Focalin XR, consider having a documented backup plan in their chart. This should include:
When the patient calls to say they can't fill their prescription, your staff can quickly pivot to the backup plan without requiring a full office visit. This reduces treatment gaps and saves clinical time.
During a shortage, small prescribing adjustments can improve your patient's chances of finding their medication:
Medication switches during a shortage often trigger prior authorization requirements. You can reduce delays by:
Many patients don't know the tools and strategies available to them. Take a moment to share:
When Focalin XR isn't available, these are the most common alternatives with approximate dose conversions:
For more details on alternatives, see Alternatives to Focalin XR.
Integrating shortage management into your practice workflow can reduce the burden on both providers and staff:
The Focalin XR shortage is a systemic problem that requires systemic solutions — increased manufacturing capacity, adjusted DEA quotas, and improved supply chain resilience. But at the point of care, you can make a meaningful difference by being proactive, flexible, and resourceful.
Your patients are already frustrated. Meeting them with a plan — rather than a shrug — builds trust and maintains treatment continuity during a challenging time.
For additional resources, visit medfinder.com/providers. For the latest shortage data, see our provider shortage briefing.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.